BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

518 related articles for article (PubMed ID: 24811054)

  • 21. Stress and the gut: pathophysiology, clinical consequences, diagnostic approach and treatment options.
    Konturek PC; Brzozowski T; Konturek SJ
    J Physiol Pharmacol; 2011 Dec; 62(6):591-9. PubMed ID: 22314561
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Commensal bacteria: the link between IBS and IBD?
    Quigley EM
    Curr Opin Clin Nutr Metab Care; 2011 Sep; 14(5):497-503. PubMed ID: 21673572
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuropharmacology of stress-induced mucosal inflammation: implications for inflammatory bowel disease and irritable bowel syndrome.
    Santos J; Alonso C; Vicario M; Ramos L; Lobo B; Malagelada JR
    Curr Mol Med; 2008 Jun; 8(4):258-73. PubMed ID: 18537634
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Coping strategies and interpersonal support in patients with irritable bowel syndrome and inflammatory bowel disease.
    Jones MP; Wessinger S; Crowell MD
    Clin Gastroenterol Hepatol; 2006 Apr; 4(4):474-81. PubMed ID: 16616353
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Microbiota, gastrointestinal infections, low-grade inflammation, and antibiotic therapy in irritable bowel syndrome: an evidence-based review.
    Schmulson M; Bielsa MV; Carmona-Sánchez R; Hernández A; López-Colombo A; López Vidal Y; Peláez-Luna M; Remes-Troche JM; Tamayo JL; Valdovinos MA
    Rev Gastroenterol Mex; 2014; 79(2):96-134. PubMed ID: 24857420
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IBD and IBS: novel mechanisms and future practice. Preface.
    Travis SP; Spiller RC; Holzer P; Colombel JF
    Dig Dis; 2009; 27 Suppl 1():1-2. PubMed ID: 20203490
    [No Abstract]   [Full Text] [Related]  

  • 27. Editorial: Can gluten contribute to irritable bowel syndrome?
    Verdu EF
    Am J Gastroenterol; 2011 Mar; 106(3):516-8. PubMed ID: 21378766
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inflammatory bowel disease versus irritable bowel syndrome: a hospital-based, case-control study of disease impact on quality of life.
    Pace F; Molteni P; Bollani S; Sarzi-Puttini P; Stockbrügger R; Bianchi Porro G; Drossman DA
    Scand J Gastroenterol; 2003 Oct; 38(10):1031-8. PubMed ID: 14621276
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immune activation in irritable bowel syndrome: can neuroimmune interactions explain symptoms?
    Hughes PA; Zola H; Penttila IA; Blackshaw LA; Andrews JM; Krumbiegel D
    Am J Gastroenterol; 2013 Jul; 108(7):1066-74. PubMed ID: 23649183
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diarrhoea-predominant irritable bowel syndrome: an organic disorder with structural abnormalities in the jejunal epithelial barrier.
    Martínez C; Lobo B; Pigrau M; Ramos L; González-Castro AM; Alonso C; Guilarte M; Guilá M; de Torres I; Azpiroz F; Santos J; Vicario M
    Gut; 2013 Aug; 62(8):1160-8. PubMed ID: 22637702
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dilemma in post-IBD patients with IBS-D symptoms: A 2020 overview.
    Tozlu M; Cash B; Younes M; Ertan A
    Expert Rev Gastroenterol Hepatol; 2021 Jan; 15(1):5-8. PubMed ID: 32990090
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tight junctions and IBS--the link between epithelial permeability, low-grade inflammation, and symptom generation?
    Piche T
    Neurogastroenterol Motil; 2014 Mar; 26(3):296-302. PubMed ID: 24548256
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The microbiome in inflammatory bowel disease and its modulation as a therapeutic manoeuvre.
    Hart AL; Hendy P
    Proc Nutr Soc; 2014 Nov; 73(4):452-6. PubMed ID: 25221893
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Putative inflammatory and immunological mechanisms in functional bowel disorders.
    Collins SM; Vallance B; Barbara G; Borgaonkar M
    Baillieres Best Pract Res Clin Gastroenterol; 1999 Oct; 13(3):429-36. PubMed ID: 10580919
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identifying and testing candidate genetic polymorphisms in the irritable bowel syndrome (IBS): association with TNFSF15 and TNFα.
    Swan C; Duroudier NP; Campbell E; Zaitoun A; Hastings M; Dukes GE; Cox J; Kelly FM; Wilde J; Lennon MG; Neal KR; Whorwell PJ; Hall IP; Spiller RC
    Gut; 2013 Jul; 62(7):985-94. PubMed ID: 22684480
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recent developments in the pathophysiology of irritable bowel syndrome.
    El-Salhy M
    World J Gastroenterol; 2015 Jul; 21(25):7621-36. PubMed ID: 26167065
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gut memories: towards a cognitive neurobiology of irritable bowel syndrome.
    Kennedy PJ; Clarke G; Quigley EM; Groeger JA; Dinan TG; Cryan JF
    Neurosci Biobehav Rev; 2012 Jan; 36(1):310-40. PubMed ID: 21777613
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An observational study of cognitive function in patients with irritable bowel syndrome and inflammatory bowel disease.
    Berrill JW; Gallacher J; Hood K; Green JT; Matthews SB; Campbell AK; Smith A
    Neurogastroenterol Motil; 2013 Nov; 25(11):918-e704. PubMed ID: 23981191
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nutrigenetics, nutrigenomics and inflammatory bowel diseases.
    Ferguson LR
    Expert Rev Clin Immunol; 2013 Aug; 9(8):717-26. PubMed ID: 23971750
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inflammation and microflora.
    Pimentel M; Chang C
    Gastroenterol Clin North Am; 2011 Mar; 40(1):69-85. PubMed ID: 21333901
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.